메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Xiaoyu Xu (The First Affiliated Hospital of Soochow University Soochow University Suzhou China) Qiongyu Lu (Soochow University Suzhou China) Zheng Wang (The First Affiliated Hospital of Soochow University Soochow University Suzhou China) Ping Cai (The First Affiliated Hospital of Soochow University Soochow University Suzhou China) Zhao Zeng (The First Affiliated Hospital of Soochow University Soochow University Suzhou China) Ling Zhang (The First Affiliated Hospital of Soochow University Soochow University Suzhou China) Man Wang (The First Affiliated Hospital of Soochow University Soochow University Suzhou China) Liang Ma (The First Affiliated Hospital of Soochow University Soochow University Suzhou China) Changgeng Ruan (The First Affiliated Hospital of Soochow University Soochow University Suzhou China) Suning Chen (The First Affiliated Hospital of Soochow University Soochow University Suzhou China)
저널정보
대한암학회 Cancer Research and Treatment Cancer Research and Treatment 제53권 제3호
발행연도
2021.1
수록면
889 - 892 (4page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Platelet-derived growth factor receptor beta (PDGFRB) rearrangements play an important role in the pathogenesis of eosinophilia-associated myeloid/lymphoid neoplasms. Up to now, more than 70 PDGFRB fusions have been identified. Here, a novel PDGFRB fusion gene CSNK2A1-PDGFRB has been identified in myeloproliferative neoplasm (MPN) with eosinophilia by RNA-sequencing, which has been verified by reverse transcription polymerase chain reaction and Sanger sequencing. The new PDGFRB fusion partner gene CSNK2A1 encoded one of the two catalytic subunit of casein kinase II (CK2). To our knowledge, this is the first report on the involvement of CSNK2A1 in fusion genes, especially fusion with another kinase PDGFRB in MPN. In addition, the CSNK2A1-PDGFRB fusion retained the entire kinase domain of PDGFRB and response to imatinib at low concentration. The patient with CSNK2A1-PDGFRB was sensitive to imatinib treatment and acquired sustained complete remission.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0